Dibenzepin
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N06AA08
CAS registry number (Chemical Abstracts Service)
0004498-32-2
Chemical Formula
C18-H21-N3-O
Molecular Weight
295
Therapeutic Category
Antidepressant, tricyclic
Chemical Name
11H-Dibenzo[b,e][1,4]diazepin-11-one, 10-[2-(dimethylamino)ethyl]-5,10-dihydro-5-methyl-
Foreign Names
- Dibenzepinum (Latin)
- Dibenzepin (German)
- Dibenzépine (French)
- Dibencepina (Spanish)
Generic Names
- Dibencepina (OS: DCIT)
- Dibenzepin (OS: BAN)
- Dibenzépine (OS: DCF)
- LW 1927 (IS)
- Dibenzepin Hydrochloride (OS: USAN)
- HF 1927 (IS: Sandoz)
Brand Names
- Noveril
Novartis, Czech Republic; Novartis, Hungary; Novartis, Israel; Novartis, Poland; Novartis, Slovakia - Noveril TR
Novartis, Switzerland
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
